[BOISE] – Attorney General Raúl Labrador today announced an $86 million multistate settlement in principle with opioid manufacturer Indivior for its role in driving the spread of deadly opioid addictions across Idaho and the country. Indivior produced buprenorphine-based products to treat opioid use disorder. However, as Attorney General Labrador and a multistate coalition of attorneys general allege, Indivior inappropriately targeted its sales to dangerous prescribers – including doctors running pill mills. Indivior also failed to monitor suspicious orders, causing its products to be inappropriately prescribed and used to fuel, rather than treat, opioid addictions.
“The greed and exploitation that fueled the opioid crisis has now spread even to those companies which purported to help solve the problem by treating those addictions,” said Attorney General Labrador. “These settlements will never put those lost lives back together, but hopefully we can avoid the wreckage of future addiction with wisely targeted investments in prevention and treatment.”
The settlement in principle announced today will provide $86 million to participating states over five years, which will be used for opioid addiction treatment, recovery, and prevention programs.
This is the fourth major opioid-related settlement negotiated by the Attorney General since taking office in 2023. So far, these settlements have added almost $80 million into statewide efforts to fight the crisis. Idaho’s portion of the Indivior settlement will be calculated when finalized.
The Indivior settlement in principle was negotiated by the attorneys general of New York, Illinois, Tennessee, Utah, and Virginia in coordination with an executive committee consisting of the attorneys general of California, Colorado, Delaware, Georgia, Idaho, Iowa, Massachusetts, North Carolina, Ohio, Oregon, and Vermont.
